单孔机器人辅助根治性前列腺切除术:SP手术系统首次临床经验
该研究报道了FDA批准新型专用单孔机器人平台后在美国的首次临床经验,两例前列腺癌患者接受单孔机器人辅助根治性前列腺切除术加双侧盆腔淋巴结清扫,均通过2.5厘米脐周切口完成,无中转,总手术时间140分钟,出血可忽略,无并发症,术后24小时内出院。
要点
- 两例前列腺癌患者成功完成单孔机器人辅助根治性前列腺切除术,无中转。
- 手术通过2.5厘米脐周切口放置多通道端口完成,总手术时间140分钟。
- 出血可忽略,无并发症记录,患者术后24小时内出院。
核心结论
- 在美国FDA批准SP手术系统后,首次记录了单孔经脐机器人辅助根治性前列腺切除术的临床应用,技术可行。
研究设计与样本
- 两例适合根治性前列腺切除术的前列腺癌男性患者,接受单孔机器人辅助根治性前列腺切除术加双侧盆腔淋巴结清扫。
主要发现
- 两例手术均成功完成,无中转,总手术时间均为140分钟。
- 出血可忽略,无并发症记录,患者术后24小时内出院。
关键数值与推荐
- 手术通过2.5厘米脐周切口进行,放置GelPOINT Mini advanced access平台和专用25毫米多通道端口。
- 多通道端口容纳12×10毫米椭圆形可铰接机器人摄像头、三个6毫米双关节可铰接机器人器械和一个6毫米辅助腹腔镜器械。
- 辅助端口置于直肠旁线水平,即计划最终引流部位。
临床怎么用
- 该初步经验提示单孔经脐机器人辅助根治性前列腺切除术在特定患者中技术可行,但需进一步研究手术并发症和结局。
局限性
- 仅两例患者,样本量小,为首次临床经验报道,需进一步研究手术并发症和结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To describe the first clinical experience with the novel purpose-built single-port robotic platform after Food Drug Administration approval. METHODS: Two male patients diagnosed with prostate cancer amenable of radical prostatectomy underwent single-port robot-assisted radical prostatectomy with bilateral pelvic lymph-nodes dissection performed by using the da Vinci SP Surgical System (Intuitive Surgical, Sunnyvale, CA). The surgeries were completed through a 2.5-cm periumbilical incision through which a GelPOINT Mini advanced access platform (Applied Medical, Rancho Santa Margarita, CA) and the dedicated 25-mm multichannel port accommodating a 12 × 10 mm oval articulating robotic camera, three 6-mm double-jointed articulating robotic instruments and a 6-mm accessory laparoscopic instrument were placed. One port for the assistant was placed at the level of the para-rectal line, at the planned final site for the drainage. The primary aim was to report, for the first time in the United States after Food Drug Administration approval of the system, the technical feasibility in the living human. The secondary aim was to report the perioperative outcomes. RESULTS: The surgeries were successfully completed without conversion. In both cases, the total operative time was 140 minutes. Blood loss was negligible. No complications were recorded. Patients were discharged within 24 hours postoperation. CONCLUSIONS: Herein, we documented the first clinical application of the SP surgical platform for single-port transumbilical robot-assisted radical prostatectomy in the United States. This approach will be further investigated regarding the surgical morbidity and the outcomes.
引用
- Kaouk J, Bertolo R, Eltemamy M, et al. Single-Port Robot-Assisted Radical Prostatectomy: First Clinical Experience Using The SP Surgical System. Urology. 2018. PMID: 30367924. doi:10.1016/j.urology.2018.10.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。